MUC1 and pachyonychia congenita: Interestingly, MUC1‐specific cytotoxic T‐lymphocytes prompted clinical studies of MUC1‐targeting vaccines in PC, and a subsequent animal experiment revealed that MUC1 could provide immune protection against cancer cells in wild‐type mice.108